BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 126 filers reported holding BIODELIVERY SCIENCES INTL IN in Q4 2015. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $15,000 | -34.8% | 8,532 | 0.0% | 0.00% | – |
| Q3 2016 | $23,000 | +15.0% | 8,532 | 0.0% | 0.00% | – |
| Q2 2016 | $20,000 | -96.3% | 8,532 | -94.9% | 0.00% | -100.0% |
| Q1 2016 | $539,000 | -33.1% | 166,988 | -0.8% | 0.00% | 0.0% |
| Q4 2015 | $806,000 | -12.8% | 168,253 | +1.2% | 0.00% | 0.0% |
| Q3 2015 | $924,000 | -30.1% | 166,188 | +0.2% | 0.00% | -50.0% |
| Q2 2015 | $1,321,000 | +2.8% | 165,918 | +35.6% | 0.00% | 0.0% |
| Q1 2015 | $1,285,000 | -11.6% | 122,374 | +1.2% | 0.00% | 0.0% |
| Q4 2014 | $1,453,000 | -29.9% | 120,897 | -0.4% | 0.00% | -33.3% |
| Q3 2014 | $2,074,000 | +42.0% | 121,359 | +0.3% | 0.00% | +50.0% |
| Q2 2014 | $1,461,000 | +68.5% | 121,035 | +17.8% | 0.00% | +100.0% |
| Q1 2014 | $867,000 | +77.3% | 102,738 | +23.6% | 0.00% | 0.0% |
| Q4 2013 | $489,000 | +5.8% | 83,093 | -2.4% | 0.00% | 0.0% |
| Q3 2013 | $462,000 | +45.7% | 85,100 | +9.1% | 0.00% | 0.0% |
| Q2 2013 | $317,000 | – | 78,016 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,575,000 | $6,615,000 | 4.38% |
| 1492 Capital Management LLC | 790,863 | $3,322,000 | 1.91% |
| Rubric Capital Management LP | 3,516,124 | $14,768,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,530,000 | $40,026,000 | 0.79% |
| Zebra Capital Management LLC | 144,241 | $606,000 | 0.77% |
| KNOTT DAVID M | 370,230 | $1,555,000 | 0.70% |
| Nantahala Capital Management | 5,123,671 | $21,519,000 | 0.67% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 3,593,893 | $15,094,000 | 0.66% |
| EMC Capital Management | 98,933 | $416,000 | 0.32% |
| ALGERT GLOBAL LLC | 175,170 | $736,000 | 0.21% |